Seeking Alpha

Medtronic (MDT) announces one-year results from its first randomized clinical trial...

Medtronic (MDT) announces one-year results from its first randomized clinical trial investigating renal denervation showing patients who initially received treatment with the Symplicity renal denervation system sustained a significant drop in blood pressure compared to baseline at 12 months, plus no device-related serious adverse events, no late vascular complications, and no significant decline in kidney function.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)